ID CP51A_MACFA Reviewed; 509 AA. AC Q4R8S6; Q4R5W7; DT 26-MAY-2009, integrated into UniProtKB/Swiss-Prot. DT 29-SEP-2021, sequence version 3. DT 24-JAN-2024, entry version 102. DE RecName: Full=Lanosterol 14-alpha demethylase {ECO:0000250|UniProtKB:Q16850}; DE Short=LDM; DE EC=1.14.14.154 {ECO:0000250|UniProtKB:Q16850, ECO:0000250|UniProtKB:Q64654}; DE AltName: Full=CYPLI; DE AltName: Full=Cytochrome P450 51A1; DE Short=CAP51 {ECO:0000250|UniProtKB:Q64654}; DE AltName: Full=Cytochrome P450-14DM; DE Short=Cytochrome P45014DM; DE AltName: Full=Cytochrome P450LI; DE AltName: Full=Sterol 14-alpha demethylase; GN Name=CYP51A1 {ECO:0000250|UniProtKB:Q16850}; Synonyms=CYP51; GN ORFNames=QtsA-11582, QtsA-20162; OS Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; OC Cercopithecidae; Cercopithecinae; Macaca. OX NCBI_TaxID=9541; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Uno Y., Kito G., Kamataki T., Nagata R.; RT "Identification of CYP cDNAs from cynomolgus monkey liver."; RL Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Testis; RG International consortium for macaque cDNA sequencing and analysis; RT "DNA sequences of macaque genes expressed in brain or testis and its RT evolutionary implications."; RL Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Sterol 14alpha-demethylase that plays a critical role in the CC cholesterol biosynthesis pathway, being cholesterol the major sterol CC component in mammalian membranes as well as a precursor for bile acid CC and steroid hormone synthesis. Cytochrome P450 monooxygenase that CC catalyzes the three-step oxidative removal of the 14alpha-methyl group CC (C-32) of sterols such as lanosterol (lanosta-8,24-dien-3beta-ol) and CC 24,25-dihydrolanosterol (DHL) in the form of formate, and converts the CC sterols to 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol and 4,4- CC dimethyl-8,14-cholestadien-3beta-ol, respectively, which are CC intermediates of cholesterol biosynthesis. Can also demethylate CC substrates not intrinsic to mammals, such as eburicol (24- CC methylene-24,25-dihydrolanosterol), but at a lower rate than DHL. CC {ECO:0000250|UniProtKB:Q64654}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 14alpha-methyl steroid + 3 O2 + 3 reduced CC [NADPH--hemoprotein reductase] = a Delta(14) steroid + formate + 4 CC H(+) + 4 H2O + 3 oxidized [NADPH--hemoprotein reductase]; CC Xref=Rhea:RHEA:54028, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:15740, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:138029, ChEBI:CHEBI:138031; EC=1.14.14.154; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54029; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=lanosterol + 3 O2 + 3 reduced [NADPH--hemoprotein reductase] = CC 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + 4 CC H(+) + 4 H2O + 3 oxidized [NADPH--hemoprotein reductase]; CC Xref=Rhea:RHEA:25286, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:15740, ChEBI:CHEBI:16521, ChEBI:CHEBI:17813, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; EC=1.14.14.154; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25287; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=24,25-dihydrolanosterol + 3 O2 + 3 reduced [NADPH--hemoprotein CC reductase] = 4,4-dimethyl-8,14-cholestadien-3beta-ol + formate + 4 CC H(+) + 4 H2O + 3 oxidized [NADPH--hemoprotein reductase]; CC Xref=Rhea:RHEA:45960, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:15740, ChEBI:CHEBI:28113, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:78904; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45961; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 14alpha-methyl steroid + O2 + reduced [NADPH--hemoprotein CC reductase] = a 14alpha-hydroxymethyl steroid + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:68060, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:138029, ChEBI:CHEBI:176901; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68061; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 14alpha-hydroxymethyl steroid + O2 + reduced CC [NADPH--hemoprotein reductase] = a 14alpha-formyl steroid + H(+) + 2 CC H2O + oxidized [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:68064, CC Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:176901, ChEBI:CHEBI:176902; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68065; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 14alpha-formyl steroid + O2 + reduced [NADPH--hemoprotein CC reductase] = a Delta(14) steroid + formate + 2 H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:68068, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:15740, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:138031, CC ChEBI:CHEBI:176902; Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68069; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=lanosterol + O2 + reduced [NADPH--hemoprotein reductase] = 32- CC hydroxylanosterol + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:75103, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:16521, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:166806; Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75104; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=32-hydroxylanosterol + O2 + reduced [NADPH--hemoprotein CC reductase] = 32-oxolanosterol + H(+) + 2 H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:75107, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:166681, ChEBI:CHEBI:166806; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75108; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=32-oxolanosterol + O2 + reduced [NADPH--hemoprotein reductase] CC = 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + 2 CC H(+) + H2O + oxidized [NADPH--hemoprotein reductase]; CC Xref=Rhea:RHEA:75111, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:15740, ChEBI:CHEBI:17813, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:166681; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75112; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=24,25-dihydrolanosterol + O2 + reduced [NADPH--hemoprotein CC reductase] = 32-hydroxy-24,25-dihydrolanosterol + H(+) + H2O + CC oxidized [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:75079, CC Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:28113, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:87057; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75080; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=32-hydroxy-24,25-dihydrolanosterol + O2 + reduced CC [NADPH--hemoprotein reductase] = 32-oxo-24,25-dihydrolanosterol + CC H(+) + 2 H2O + oxidized [NADPH--hemoprotein reductase]; CC Xref=Rhea:RHEA:75087, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:87057, CC ChEBI:CHEBI:87060; Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75088; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- CATALYTIC ACTIVITY: CC Reaction=32-oxo-24,25-dihydrolanosterol + O2 + reduced CC [NADPH--hemoprotein reductase] = 4,4-dimethyl-8,14-cholestadien- CC 3beta-ol + formate + 2 H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:75083, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:15740, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:78904, ChEBI:CHEBI:87060; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75084; CC Evidence={ECO:0000250|UniProtKB:Q64654}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; CC Evidence={ECO:0000250|UniProtKB:Q16850}; CC -!- ACTIVITY REGULATION: Inhibited by azalanstat. Inhibited by azole CC antifungal agents ketoconazole, itraconazole and fluconazole. CC {ECO:0000250|UniProtKB:Q64654}. CC -!- PATHWAY: Steroid biosynthesis; zymosterol biosynthesis; zymosterol from CC lanosterol: step 1/6. {ECO:0000250|UniProtKB:Q64654}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:Q64654}; Single-pass membrane protein CC {ECO:0000255}. Microsome membrane {ECO:0000250|UniProtKB:Q64654}; CC Single-pass membrane protein {ECO:0000255}. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC -!- CAUTION: It is uncertain whether Met-1 or Met-7 is the initiator. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAE01508.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; DQ074804; AAZ29450.1; -; mRNA. DR EMBL; AB168372; BAE00495.1; -; mRNA. DR EMBL; AB169425; BAE01508.1; ALT_INIT; mRNA. DR RefSeq; NP_001274625.1; NM_001287696.1. DR AlphaFoldDB; Q4R8S6; -. DR SMR; Q4R8S6; -. DR STRING; 9541.ENSMFAP00000041467; -. DR Ensembl; ENSMFAT00000015743.2; ENSMFAP00000041467.1; ENSMFAG00000041456.2. DR VGNC; VGNC:83109; CYP51A1. DR eggNOG; KOG0684; Eukaryota. DR GeneTree; ENSGT00930000151026; -. DR OMA; AWTLIEL; -. DR OrthoDB; 5474434at2759; -. DR UniPathway; UPA00770; UER00754. DR Proteomes; UP000233100; Chromosome 3. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell. DR GO; GO:0020037; F:heme binding; ISS:UniProtKB. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0008398; F:sterol 14-demethylase activity; ISS:UniProtKB. DR GO; GO:0006695; P:cholesterol biosynthetic process; IEA:UniProtKB-KW. DR GO; GO:0006694; P:steroid biosynthetic process; ISS:UniProtKB. DR CDD; cd11042; CYP51-like; 1. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR002403; Cyt_P450_E_grp-IV. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24304:SF2; 24-HYDROXYCHOLESTEROL 7-ALPHA-HYDROXYLASE; 1. DR PANTHER; PTHR24304; CYTOCHROME P450 FAMILY 7; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00465; EP450IV. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. DR PROSITE; PS00086; CYTOCHROME_P450; 1. PE 2: Evidence at transcript level; KW Cholesterol biosynthesis; Cholesterol metabolism; Endoplasmic reticulum; KW Heme; Iron; Lipid biosynthesis; Lipid metabolism; Membrane; Metal-binding; KW Microsome; Monooxygenase; Oxidoreductase; Reference proteome; KW Steroid biosynthesis; Steroid metabolism; Sterol biosynthesis; KW Sterol metabolism; Transmembrane; Transmembrane helix. FT CHAIN 1..509 FT /note="Lanosterol 14-alpha demethylase" FT /id="PRO_0000052000" FT TRANSMEM 30..50 FT /note="Helical" FT /evidence="ECO:0000255" FT BINDING 455 FT /ligand="heme" FT /ligand_id="ChEBI:CHEBI:30413" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000250|UniProtKB:Q16850" SQ SEQUENCE 509 AA; 57287 MW; 681FFF7E95B2CBCC CRC64; MAAAAGMMLL GLLQAGGSVL GQAMEKVTGG NLLSMLLIAC AFTLSLVYLF RLAAGHLVQL PAGAKSPPYI FSPIPFLGHA IAFGKSPVEF LENAYEKYGP VFSFTMVGKT FTYLLGSDAA ALLFNSKNED LNAEDVYSRL TTPVFGKGVA YDVPNPVFLE QKKMLKSGLN IAHFKQHVSI IEKETKEYFQ SWGESGEKNV FEALSELIIL TASHCLHGKE IRSQLNEKVA QLYADLDGGF SHAAWLLPGW LPLPSFRRRD RAHREIKNIF YKAIQKRRQS QEKIDDILQT LLDATYKDGR PLTDDEVAGM LIGLLLAGQH TSSTTSAWMG FFLARDKTLQ EKCYLEQKTV CGENLPPLTY DQLKDLNLLD RCIKETLRLR PPIMIMMRMA RTPQTVAGYT IPPGHQVCVS PTVNQRLKDS WVERLDFNPD RYLQDNPASG EKFAYVPFGA GRHRCIGENF AYVQIKTIWS TMLRLYEFDL IDGYFPTVNY TTMIHTPENP VIRYKRRSK //